EDA: Workshop on the rules and procedures for issuing import approvals and customs medical release letters.

EDA: Completion of a workshop on the regulatory aspects of ethics in clinical medical research in Egypt.

EDA: Workshop on the latest updates to ISO 13485 standards for medical devices and laboratory/diagnostic reagents.

EDA: Conclusion of the training program on International Council for Harmonisation (ICH) guidelines for pharmaceutical impurities.

EDA: Completion of the training program on data integrity and Annex I requirements.

EDA: Egyptian Drug Authority concludes the training program on regulatory reliance mechanisms in collaboration with Acino Pharma.

In line with the Egyptian Drug Authority’s commitment to enhancing the capabilities of human resources in the pharmaceutical sector through distinguished training programs—designed by the Center for Continuing Professional Development—and in recognition of the Authority’s vital role in providing technical support, direct engagement with industry partners, supporting institutional excellence programs for EDA staff, and raising pharmaceutical awareness through specialized training programs:

The EDA announced the completion of a workshop on the rules and procedures for import and customs medical release of pharmaceutical products.

The Authority also completed a workshop on the regulatory aspects of ethics in clinical medical research in Egypt.

Additionally, the EDA announced the conclusion of a workshop on the latest ISO 13485 standards for medical devices and laboratory/diagnostic reagents, presented by MRG, a global multinational company.

The training program titled “Regulatory Guidelines of the International Council for Harmonisation (ICH): Pharmaceutical Impurities” was also completed, organized by the Center for Continuing Professional Development in cooperation with the ICH.

Completion of the training program on Data Integrity and Annex I Requirements was achieved, organized in collaboration with IETQAN Conformity and Certification.

Finally, the training program on the Regulatory Reliance System was completed, organized in collaboration with Acino Pharma.

It is noteworthy that a total of 327 trainees from various stakeholders in the pharmaceutical sector participated in these training programs and workshops.

These initiatives are part of the Egyptian Drug Authority’s ambitious plan to enhance the professional capabilities of all employees across the pharmaceutical sector, keeping them up-to-date with developments in all fields, contributing to the development of effective human resources capable of achieving institutional excellence, and supporting cooperation with the private sector, in alignment with Egypt’s Sustainable Development Goals under Vision 2030.